Literature DB >> 15319474

Polymorphisms of cardiac presynaptic alpha2C adrenergic receptors: Diverse intragenic variability with haplotype-specific functional effects.

Kersten M Small1, Jeanne Mialet-Perez, Carrie A Seman, Cheryl T Theiss, Kari M Brown, Stephen B Liggett.   

Abstract

The presynaptic alpha2C adrenergic receptors (AR) act to inhibit norepinephrine release in cardiac and other presynaptic nerves. We have recently shown that a genetic variant in the alpha2CAR coding region (Del322-325), which renders the receptor partially uncoupled from Gi, is a risk factor for heart failure. However, variability of heart failure phenotypes and a dominance of Del322-325 in those of African descent led us to hypothesize that other regions of this gene have functional polymorphisms. In a multiethnic population, we found 20 polymorphisms within 4,625 bp of contiguous sequence of this intronless gene encompassing the promoter, 5' UTR, coding, and 3' UTR. These polymorphisms occur in 24 distinct haplotypes with complex organizations, including multiple 5'-upstream polymorphisms in regions known to direct expression, a 3' UTR substitution polymorphism within an insertion/deletion sequence, and the radical coding polymorphism that deletes four amino acids. Relatively low linkage disequilibrium between many polymorphisms, few cosmopolitan haplotypes, prevalent ethnic-specific haplotypes, and substantial genetic divergence among haplotypes was noted. The dysfunctional Del322-325 allele was partitioned into multiple haplotypes, with frequencies of 48% to 2%. The functional implications of the haplotypes were ascertained by whole-gene transfections of human neuronal cells, where haplotype was significantly related (P < 0.001) to expression levels of receptor transcript and protein. Expression varied by as much as approximately 50% by haplotype, and such studies enabled haplotype clustering by phenotypic, rather than genotypic, similarities. Thus, depending on phenotype, expression-specific haplotypes may amplify, attenuate, or dominate the cardiomyopathic effect attributed to the alpha2CDel322-325 marker. Copyright 2004 The National Academy of Sciencs of the USA

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15319474      PMCID: PMC516511          DOI: 10.1073/pnas.0405074101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Haplotype variation and linkage disequilibrium in 313 human genes.

Authors:  J C Stephens; J A Schneider; D A Tanguay; J Choi; T Acharya; S E Stanley; R Jiang; C J Messer; A Chew; J H Han; J Duan; J L Carr; M S Lee; B Koshy; A M Kumar; G Zhang; W R Newell; A Windemuth; C Xu; T S Kalbfleisch; S L Shaner; K Arnold; V Schulz; C M Drysdale; K Nandabalan; R S Judson; G Ruano; G F Vovis
Journal:  Science       Date:  2001-07-12       Impact factor: 47.728

Review 2.  Pharmacology and physiology of human adrenergic receptor polymorphisms.

Authors:  Kersten M Small; Dennis W McGraw; Stephen B Liggett
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002-01-10       Impact factor: 13.820

Review 3.  Why does the myocardium fail? Insights from basic science.

Authors:  M R Bristow
Journal:  Lancet       Date:  1998-08       Impact factor: 79.321

4.  Molecular cloning, sequencing and functional study of the promoter region of the human alpha2C4-adrenergic receptor gene.

Authors:  S Schaak; J C Devedjian; C Cayla; Y Sender; H Paris
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

5.  Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission.

Authors:  L Hein; J D Altman; B K Kobilka
Journal:  Nature       Date:  1999-11-11       Impact factor: 49.962

6.  The 3'-untranslated region of the alpha2C-adrenergic receptor mRNA impedes translation of the receptor message.

Authors:  Q Yang; P J McDermott; E Duzic; C W Pleij; J D Sherlock; S M Lanier
Journal:  J Biol Chem       Date:  1997-06-13       Impact factor: 5.157

7.  A four amino acid deletion polymorphism in the third intracellular loop of the human alpha 2C-adrenergic receptor confers impaired coupling to multiple effectors.

Authors:  K M Small; S L Forbes; F F Rahman; K M Bridges; S B Liggett
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

8.  The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma.

Authors:  E Israel; J M Drazen; S B Liggett; H A Boushey; R M Cherniack; V M Chinchilli; D M Cooper; J V Fahy; J E Fish; J G Ford; M Kraft; S Kunselman; S C Lazarus; R F Lemanske; R J Martin; D E McLean; S P Peters; E K Silverman; C A Sorkness; S J Szefler; S T Weiss; C N Yandava
Journal:  Am J Respir Crit Care Med       Date:  2000-07       Impact factor: 21.405

9.  Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure.

Authors:  Kersten M Small; Lynne E Wagoner; Albert M Levin; Sharon L R Kardia; Stephen B Liggett
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

10.  Human tissue adrenergic receptors are not predictive of responses to epinephrine in vivo.

Authors:  S B Liggett; S D Shah; P E Cryer
Journal:  Am J Physiol       Date:  1989-05
View more
  22 in total

Review 1.  A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3' UTR variants.

Authors:  Jian-Min Chen; Claude Férec; David N Cooper
Journal:  Hum Genet       Date:  2006-06-29       Impact factor: 4.132

2.  Generalized genomic distance-based regression methodology for multilocus association analysis.

Authors:  Jennifer Wessel; Nicholas J Schork
Journal:  Am J Hum Genet       Date:  2006-09-21       Impact factor: 11.025

3.  Alpha-adrenoceptor gene variants and autonomic nervous system function in a young healthy Japanese population.

Authors:  Tetsuro Matsunaga; Koichiro Yasuda; Tetsuya Adachi; Ning Gu; Tsubasa Yamamura; Toshio Moritani; Gozoh Tsujimoto; Kinsuke Tsuda
Journal:  J Hum Genet       Date:  2006-10-31       Impact factor: 3.172

4.  Tight control of adrenal medulla catecholamine release by alpha 2C-adrenergic receptors influences susceptibility to heart failure.

Authors:  Natalia Petrashevskaya; Stephen B Liggett
Journal:  Cardiovasc Res       Date:  2007-07-16       Impact factor: 10.787

Review 5.  Mechanisms of pharmacogenomic effects of genetic variation within the cardiac adrenergic network in heart failure.

Authors:  Gerald W Dorn; Stephen B Liggett
Journal:  Mol Pharmacol       Date:  2009-06-02       Impact factor: 4.436

6.  The Gordon Wilson Lecture: neurohormonal signaling pathways that link cardiac growth and death.

Authors:  Gerald W Dorn
Journal:  Trans Am Clin Climatol Assoc       Date:  2007

Review 7.  Intracellular α(2C)-adrenoceptors: storage depot, stunted development or signaling domain?

Authors:  Maqsood A Chotani; Nicholas A Flavahan
Journal:  Biochim Biophys Acta       Date:  2011-05-14

8.  Genetic variation in alpha2-adrenoreceptors and heart rate recovery after exercise.

Authors:  Utkarsh Kohli; André Diedrich; Prince J Kannankeril; Mordechai Muszkat; Gbenga G Sofowora; Maureen K Hahn; Brett A English; Randy D Blakely; C Michael Stein; Daniel Kurnik
Journal:  Physiol Genomics       Date:  2015-06-09       Impact factor: 3.107

9.  The association of an alpha2C adrenoreceptor gene polymorphism with vasomotor symptoms in African American women.

Authors:  Devora A Aharon; Elissa Gretz Friedman; Jessica R Overbey; Maryann McLaughlin; Taimour Langaee; Rebecca C Thurston
Journal:  Menopause       Date:  2019-03       Impact factor: 2.953

10.  The alpha2C-adrenoceptor deletion322-325 variant and cold-induced vasoconstriction.

Authors:  Eitan A Friedman; Paul A Harris; Alastair J J Wood; C Michael Stein; Daniel Kurnik
Journal:  Clin Auton Res       Date:  2009-05-15       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.